Thursday, October 11, 2018
In this LIVE Webcast, a panel of key thought leaders organized by The Knowledge Group will provide the audience with an overview of chemical and life sciences patent updates in 2018. Speakers, among other things, will offer helpful insights on the significant effects of last year's developments on upcoming cases. They will also provide the audience with practical tips in devising a comprehensive program that will monitor significant changes.
Co-speaker Keith Fredlake's presentation will include:
- Patent eligibility – Vanda memo
- Patent indefiniteness – Teva, Nautilus
- AIA – on sale bar – Helsinn
- Markush claims – Shire Dev
Course Fee: Registration is FREE courtesy of Kilpatrick Townsend & Stockton LLP. Please note, complimentary passes are available for the first 30 registrants. Once all of the passes are used, attendees can register for the deeply discounted rate of $25 each courtesy of Kilpatrick Townsend & Stockton LLP. Discount code KILPATRICK147373 is applied automatically when you click "Register Now".
Event Details
Thursday, October 11, 2018
LIVE Webcast
CLE Credit
Course Level:
Intermediate
Advance Preparation:
Print and review course materials
Method Of Presentation:
Live Webcast
Prerequisite:
Experience in intellectual property law
Course Code:
147373
NY Category of CLE Credit:
Areas of Professional Practice
Total Credit:
1.0 CLE
Disclaimer
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.
